News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
June 27, 2018
Repligen Announces Agreement with Navigo Proteins for the Exclusice Co-Development of Next Generation Affinity Ligands
News
November 1, 2017
Purolite Selects Repligen's Market-Leading OPUS® Pre-Packed Columns
PR Newswire
News
October 3, 2017
Balancing the up and downstream: Repligen CEO talks R&D and M&A
Dan Stanton BioPharma Reporter
News
June 23, 2017
Repligen agrees to buy Spectrum for $359 milion
Robert Weisman Boston Globe
Announcements
June 23, 2017
Repligen Corporation and Spectrum Inc. to Join Forces
News
March 8, 2017
Repligen to up column production on back of 'milestone year of chromatography'
Dan Stanton BioPharma Reporter
News
December 20, 2016
Repligen adds single-use filtration technology through TangenX acquisition
Dan Stanton BioPharma Reporter
News
December 15, 2016
Repligen pays $40 milion to buy TangenX™ Technology
Robert Weisman Boston Globe
Announcements
December 15, 2016
Repligen acquires TangenX Technology Corporation
News
October 13, 2016
Repligen Launches Single-use Version of its Cell Retention Technology
Dan Stanton BioPharma Reporter
Announcements
October 4, 2016
Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification
News
May 11, 2016
Special Report on Continuous Bioprocessing: Upstream, Downstream, ready for Prime Time?
Angelo DePalma, BioProcessing International